Sort
21,281 grants matching “influenza”
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals
$748,045Anna Karolina Palucka · Baylor Research Institute · U19 · FY2014 · AI
Bi-functional Polymer-Attached Inhibitors of Influenza Viruses
$747,992Jianzhu Chen · Massachusetts Institute Of Technology · U01 · FY2009 · AI
Research Project 1 - The pregnancy ImmunOME
$747,949Andrea Goldberg Edlow · Massachusetts Institute Of Technology · U19 · FY2023 · AI
In vivo interrogation of the genetic and biochemical networks controlling influe
$747,686Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Systems Pathogenomics of Severe Acute Respiratory Virus Infection
$747,616Ralph S Baric · Oregon Health & Science University · U54 · FY2009 · AI
Animal Core
$747,544David S Perlin · Columbia University Health Sciences · U54 · FY2009 · AI
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$747,061Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2022 · HL
Integrating epidemiologic and environmental approaches to understand and predict Coccidioides exposure and coccidioidomycosis emergence
$747,060Justin V Remais · University Of California Berkeley · R01 · FY2022 · AI
The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD
$746,929Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.
$746,924Jose M Galarza · Technovax, Inc. · R44 · FY2018 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection
$746,786Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection
$746,786Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection
$746,786Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo
$746,690Ge Liu · Vaxinnate Corporation · R01 · FY2013 · AI
Systems Pathogenomics of Severe Acute Respiratory Virus Infection
$746,369Ralph S Baric · Oregon Health & Science University · U54 · FY2012 · AI
Development of novel isoflavone drugs as broad spectrum antivirals
$746,345Kristin M Bedard · Kineta, Inc. · R44 · FY2017 · AI
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine
$746,327Pamuk Bilsel · Flugen, Inc. · R42 · FY2017 · AI
Protein and Polysaccharide Conjugate Vaccines to enteric diseases
$746,291Shousun C Szu · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammation
$745,780Peter M Henson · National Jewish Health · R01 · FY2022 · HL
High-throughput, single-molecule sequence analysis of virus populations in vivo
$745,679Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Genomics Core
$745,563Christopher W Benner · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Advancing a broad-spectrum anti-influenza A virus RNA packaging inhibitor to an IND
$745,482Jeffrey S Glenn · Stanford University · R01 · FY2020 · AI
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$745,302Jennifer K Hoffman · Duke University · R01 · FY2025 · AI
Collaborative Research: Algorithms for Threat Detection via Geometry of Virus Genome Space
$745,188Stephen S. T Yau · University Of Illinois At Chicago · · FY2011 · MPS
Role of alterations in the ATII cell lipidome in influenza pathogenesis
$745,184Ian Christopher Davis · Ohio State University · R01 · FY2020 · HL